EPIDEMIOLOGY
Age-Related Eye Disease, Visual Impairment,
and Survival
The Beaver Dam Eye Study
MichaelD.Knudtson,MS;BarbaraE.K.Klein,MD,MPH;RonaldKlein,MD,MPH
Objective:Toinvestigatetherelationshipofage-related 1.06-1.37),anycataract(HR,1.16;95%CI,1.03-1.32),
maculopathy,cataract,glaucoma,visualimpairment,and diabeticretinopathy(HRper1-stepincreasein4-levelse-
diabeticretinopathytosurvivalduringa14-yearperiod. verity,1.36;95%CI,1.14-1.63),andvisualimpairment
(HR,1.24;95%CI,1.04-1.48)andmarginallyassociated
Methods:Personsranginginagefrom43to84yearsin withincreasingseverityofnuclearsclerosis(HR,1.07;95%
theperiodfromSeptember15,1987,toMay4,1988,par- CI,0.99-1.16).Age-relatedmaculopathyandglaucoma
ticipatedinthebaselineexaminationofthepopulation-based
were not associated with poorer survival. Associations
BeaverDamEyeStudy(n=4926).Standardizedprotocols,
tendedtobeslightlystrongerinmenthanwomen.
includingphotography,wereusedtodeterminethepres-
enceofoculardisease.Survivalwasfollowedusingstandard-
Conclusions:Cataract,diabeticretinopathy,andvisual
izedprotocols.
impairmentwereassociatedwithpoorersurvivalandnot
explainedbytraditionalriskfactorsformortality.These
Results:AsofDecember31,2002,32%ofthebaseline
ocularconditionsmayserveasmarkersformortalityinthe
populationhaddied(medianfollow-up,13.2years).Af-
generalpopulation.
teradjustingforage,sex,andsystemicandlifestylefac-
tors,poorersurvivalwasassociatedwithcorticalcataract
(hazardratio[HR],1.21;95%confidenceinterval[CI], ArchOphthalmol.2006;124:243-249
M
ANY STUDIES HAVE IN- METHODS
vestigated associa-
tions between ocular SUBJECTS
disorders and sur-
TheBeaverDamEyeStudypopulationhasbeen
vival.1-23 In general,
describedindetailelsewhere.24Briefly,aprivate
personswithoculardisordershavebeen censusofthepopulationofBeaverDam,Wis,was
showntohaveanincreasedmortalityrisk performedfromSeptember15,1987,toMay4,
compared with persons without the dis- 1988.Eligibilityrequirementsforentryintothe
orders. These associations have been studyincludedlivinginthecityortownshipof
shown with cataract,1,2,4,6,9,13-16,18-21 glau- BeaverDamandbeing43to84yearsofageatthe
timeofthecensus.Atotalof5924individualswere
coma,7diabeticretinopathy,8,10,22,23andvi-
eligibletoparticipate,ofwhom4926participated
sualimpairment4,9,11,12,17,19andrecentlywith
inthebaselineexaminationbetweenMarch1,
age-related maculopathy (ARM).3,4 In 1988,andSeptember14,1990.Differencesbe-
many instances, these associations can tweenparticipantsandnonparticipantshavebeen
beexplainedbycontrollingforsystemic presentedpreviously.24Follow-upexaminations
mortalityriskfactorsbecauseoculardis- wereconductedat5(n=3722)and10(n=2962)
yearsafterthebaselineexamination.Ninety-nine
orders are associated with these factors.
percentofthepopulationwaswhite.Alldatawere
However, some studies do not show as-
collectedwithinstitutionalreviewboardapproval
sociations with ocular disease and mor-
inconformitywithallfederalandstatelaws,and
tality.2,5,19Differencesinstudydesign,mor- thestudywasinadherencetothetenetsoftheDec-
talityfollow-up,anddefinitionsofthese larationofHelsinki.
ocular conditions may explain some of
AuthorAffiliations: theseinconsistencies.Inthepresentstudy, PROCEDURESANDDEFINITIONS
DepartmentofOphthalmology
we extend a previous study of mortality
andVisualSciences, Participantswereexaminedatthestudysuiteat
and eye disease from our group9 in the
UniversityofWisconsin alocalhospitalornursinghome.Heightandbody
SchoolofMedicine large population-based Beaver Dam Eye weightweremeasuredwithparticipantswearing
andPublicHealth,Madison. Studyto14yearsoffollow-up. lightclothingandnoshoes.Thepulseratewas
(REPRINTED)ARCHOPHTHALMOL/VOL124, FEB2006 WWW.ARCHOPHTHALMOL.COM
243
©2006AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archopht.jamanetwork.com/ by a UNIVERSITAETSBIBLIOTHEK GIESSEN User on 05/29/2015
measured.Bloodpressurewasmeasuredwitharandom-zerosphyg- withnoorsmalldrusenonlyandnopigmentabnormalitieswere
momanometeraccordingtotheHypertensionDetectionandFollow- consideredtohavenoARM.Personswithsignsofgeographic
upProgramprotocol,25andtheaverageofthe2measurementswas atrophy or exudative macular degeneration (ie, retinal pig-
usedforanalysis.Hypertensionstatuswasdefinedasameansys- mentepithelialdetachment,subretinalhemorrhage,fibrousscar,
tolicbloodpressureof140mmHgormore,meandiastolicblood ortreatment)wereconsideredtohavelateARM.Allotherper-
pressureof90mmHgormore,orcurrentuseofantihypertensive sonswereconsideredtohaveearlyARM.
medications.Nonfastingbloodandurinespecimenswerecollected. Theprocedurestodetectanddefineopen-angleglaucomahave
Measurementsobtainedincludedlevelsofserumcholesterol(total beendescribedelsewhere.32Briefly,thepresenceofatleast2ofthe
andhigh-densitylipoprotein),glycosylatedhemoglobin,random 3followingcriteriainthesameeyewasnecessaryforinclusionas
bloodglucose,grossproteinuria,hematocrit,serumalbumin,and adefinitecaseofglaucoma:avisualfieldabnormalityconsistent
serumcreatinineandawhitebloodcellcount.26Diabeteswasde- withthediagnosisofglaucoma;acup-discratioofatleast0.8or
finedasahistoryofdiabetesorhyperglycemia.Hyperglycemiawas asymmetryofatleast0.2betweentheeyes;oranintraocularpres-
definedasaglycosylatedhemoglobinlevelofmorethan2SDsabove sureof21mmHgorgreater.Ahistoryofusingdropsorhaving
themeanfortheappropriateageandsexgrouporacasualblood hadsurgeryforglaucomawithorwithoutanyofthepreviouscri-
glucoselevelof200mg/dLormore((cid:1)1.1mmol/L).27 teriawasdefinedasaprobableglaucomacase.Forpurposesofthis
Astandardizedquestionnairewasadministeredtocollectin- analysis,probableanddefinitecaseswerecombined.
formationonmedicalhistory,currentmedicationuse,smoking Diabeticretinopathywasmeasuredonan18-levelscalede-
status,alcoholuse,andphysicalactivity.26Ahistoryofcardiovas- finedelsewhere.33Thescalewasreducedtoa4-levelseverity
culardiseasewasdefinedasahistoryofangina,myocardialinfarc- scaleofno,mild,moderate,andproliferativeretinopathy.Analy-
tion,and/orstroke.Smokerswereidentifiedbyansweringyesto sesofretinopathyaregivenonlyforsubjectswithdiabetes.
smokingatleast100cigarettesintheirlifetimes.Theirstatuswas Vitalstatuswasmonitoredbyreadingtheobituariesoflocal
furthercategorizedasacurrentsmokeriftheyhadnotstoppedsmok- newspapersandbymakingannualtelephonecontact.Personsnot
ingatthebaselineexamination.Pack-yearsweredefinedasthenum- knowntohavedied,butwhomwecouldnotreach,hadtheirsur-
berofpackssmokedperdaymultipliedbythenumberofyears vivaltimeenteredastheirlastcontactdate.Whenadeathwasiden-
smoked.Heavydrinkerswereidentifiedbyansweringyestoever tifiedinthestateofWisconsin,arequestwasmadetotheWis-
havingaperiodintheirlifewhentheyconsumed4ormorealco- consinDepartmentofHealthandFamilyServices,DivisionofHealth
holicbeveragesonadailybasis.Participantswereaskediftheyen- CareFinancing,BureauofHealthInformation,VitalRecordsSec-
gagedinaregularactivitylongenoughtoworkupasweat.Per- tion,fordeathcertificateinformationaboutthesepersons.Names
sonswhoonaverageengagedinsuchactivitieslessthan3times ofpersonsknowntohavediedoutsideofWisconsinandthose
aweekwereconsideredtohaveasedentarylifestyle. withwhomwelostcontact(nocontactsinceDecember31,2002)
Refractionandmeasurementofthevisualacuitywasper- butwerenotknowntobedeadweresubmittedtotheNational
formedusingamodificationoftheEarlyTreatmentDiabeticReti- DeathIndexformatchingagainstnationaldeathdata.Weascer-
nopathyStudyprotocol.28Visualimpairmentwasdefinedasabest tainedmortalityafterthebaseline1988-1990examinationtoDe-
correctedvisualacuityof20/40orworseinthebettereyeand cember31,2002.Causeofdeathwasdefinedasanycontribut-
includedeyesthatwereblind(visualacuityof20/200orworse). ingcauselistedinthedeathcertificateaccordingtothecodesof
Thesubjects’pupilswerepharmacologicallydilated,exceptfor theInternationalClassificationofDiseases,NinthRevision(ICD-
thosepersonswithnarrowanteriorchamberangles.Aslitlampcam- 9)fordeathsbeforeDecember31,1998,andInternationalClas-
era(TopconSL;TopconAmericaCorp,Paramus,NJ)wasused sificationofDiseases,10thRevision(ICD-10)fordeathsthereafter.
toobtainphotographsofthelensofeacheye.29Thesephotographs Heartdiseasemortalitywasdefinedaccordingtocodes391.0-398.9,
weregradedforthepresenceandseverityofnuclearsclerosis.29Grad- 402.0-402.9,404.0-404.9,and410.0-429.9fromICD-9andI01.0-
ingsofseveritywereassignedona5-stepscale,andthepresence I09.9,I11.0-I11.9,I13.0-I13.9,andI20.0-I51.9fromICD-10.Can-
ofnuclearcataractwasdefinedaslevel4orlevel5.Anteriorand cermortalitywasdefinedtoincludedeathsaccordingtocodes140.0-
posteriorretroilluminationphotographsofthelenswereobtained 208.9fromICD-9andC00.0-C97.9fromICD-10.Strokemortal-
(NeitzCRT;NeitzInstrumentsCo,Ltd,Tokyo,Japan)andgraded itywasdefinedtoincludedeathsaccordingtocodes430.0-438.9
forthepresenceandseverityofcorticalandposteriorsubcapsu- fromICD-9andI60.0–I69.9fromICD-10.
larcataracts.29Ameasuringgridwasusedtodividetheretroillu-
minationphotographsintoacentralcircularareaand8sectorsof STATISTICS
equalsize.Corticalcataractwasconsideredtobepresentif5%or
moreofthelenssurfacewasaffected.Posteriorsubcapsularcata- Fortheocularconditions,when2eyeswerediscrepantinthe
ractwasconsideredtobepresentif5%ormoreofthesurfacearea presenceofalesion,thegradeassignedforthepersonwasthat
ofanyofthe8sectorsorthecentralcircularareaofthegridwas ofthemoreseverelyinvolvedeye.Incontrast,weusedthebetter-
involved.Anycataractwasdefinedasthepresenceofnuclear,cor- seeingeyetodefinevisualimpairment.WeusedSASsoftware,
tical,orposteriorsubcapsularcataractorifthelenshadbeenre- version9,forallstatisticalanalyses.34Simplestatisticsincluded
movedduringcataractsurgery. computationofmeans,proportions,and(cid:2)2andunpairedttests.
Stereoscopic30°colorfundusphotographscenteredonthe Forunivariateanalyses,estimatesofsurvivalwerecomputedwith
disc(DiabeticRetinopathyStudystandardfield1)andmacula theproduct-limitmethodofKaplanandMeier.Testsofsignifi-
(DiabeticRetinopathyStudystandardfield2)andanonstereo- cancewereperformedwiththelog-ranktest.Adjustmentsfor
scopiccolorfundusphotographtemporaltobutincludingthe age,sex,andotherriskfactorsweremadeusingCoxproportional
foveaofeacheyewereobtained.28Additionalfundusphotographs hazardsmodels.Includingasquaredorcubictermforagewas
wereobtainedofanylesionsfoundoutsidethesefields(eg,dia- notsignificantinthemodels.Similarly,adjustmentforageus-
beticretinopathylesions). ing4agegroupsin10-yearbandswasnotasstrongapredictor
GradingforARMwasperformedinamaskedfashionwith asusingagelinearly.Therefore,wedeterminedthatusingage
useoftheWisconsinAge-RelatedMaculopathyGradingSys- linearlywasthemostappropriateageadjustment.Wetestedthe
tem.30,31Thesystemassessesthepresenceandseverityof14 proportionalityassumptionbyincludinganinteractionbetween
lesionsassociatedwithARM.Moredetailsontheselesionsap- survivaltimeandtheriskfactorofinterest.35
pearelsewhere.30,31Individuallesions(eg,largedrusenandreti- Multivariate adjustment was investigated using several
nal pigment epithelial depigmentation) were each investi- methods. First, a propensity score was determined for each
gatedseparatelyandasa3-levelseverityscaleofARM.Persons oftheoculardiseaseriskfactors.Therationaleandmethods
(REPRINTED)ARCHOPHTHALMOL/VOL124, FEB2006 WWW.ARCHOPHTHALMOL.COM
244
©2006AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archopht.jamanetwork.com/ by a UNIVERSITAETSBIBLIOTHEK GIESSEN User on 05/29/2015
Table1.CharacteristicsofPopulationatBaselinebySurvivalStatus:BeaverDamEyeStudy,1988-1990
Survivors Died
No.of No.of P
Characteristic Subjects* Mean(SD) Subjects* Mean(SD) Value
Age,y 3350 58.1(9.6) 1576 70.4(9.7) (cid:3).001
Systolicbloodpressure,mmHg 3350 129.6(19.0) 1573 137.6(22.4) (cid:3).001
Diastolicbloodpressure,mmHg 3350 78.5(10.4) 1573 74.8(11.7) (cid:3).001
Serumtotalcholesterollevel,mg/dL 3340 234.0(43.0) 1566 233.0(46.0) .34
SerumHDLcholesterollevel,mg/dL 3336 53.0(17.0) 1567 50.0(18.0) (cid:3).001
Ratiooftotal-HDLcholesterollevel 3335 4.89(1.88) 1566 5.19(2.12) (cid:3).001
BMI 3341 28.8(5.2) 1540 28.7(5.8) .83
Alcoholconsumption,g/wk 3338 59.5(127.7) 1564 43.9(98.6) (cid:3).001
Glycosylatedhemoglobinlevel,% 3337 5.90(1.31) 1566 6.57(2.06) (cid:3).001
Pulserate,beats/min 3350 38.1(5.6) 1574 38.5(6.4) .04
Pack-yearssmoked 3337 15.2(23.2) 1557 23.0(33.1) (cid:3).001
Survivors, Died, P
No.(%)* No.(%)* Value
Male 3350(42.0) 1576(48.0) (cid:3).001
Diabetespresent 3336(5.7) 1563(16.3) (cid:3).001
Hypertensionpresent 3348(44.7) 1569(63.2) (cid:3).001
Cardiovasculardiseasehistorypresent 3314(8.6) 1541(29.0) (cid:3).001
Cancerhistorypresent 3345(8.9) 1570(18.2) (cid:3).001
Emphysemahistorypresent 3340(1.3) 1564(7.4) (cid:3).001
Gouthistorypresent 3343(6.7) 1562(11.1) (cid:3).001
Arthritishistorypresent 3335(34.7) 1558(46.9) (cid:3).001
Grossproteinuriapresent 3336(5.7) 1563(16.3) (cid:3).001
Sedentarylifestylepresent 3350(74.1) 1574(82.1) (cid:3).001
Currentsmoker 3348(19.5) 1573(20.1) .68
Currentheavydrinker 3345(2.6) 1564(1.9) .17
Lessthanhighschooleducation 3347(21.0) 1573(46.9) (cid:3).001
Currentmultivitaminuse 3350(25.3) 1576(24.8) .73
Currentaspirinuse 3346(21.5) 1568(27.9) (cid:3).001
Currentdiureticuse 3304(20.2) 1538(41.7) (cid:3).001
Abbreviations:BMI,bodymassindex(calculatedasweightinkilogramsdividedbythesquareofheightinmeters);HDL,high-densitylipoprotein.
SIconversionfactor:Toconvertcholesteroltomillimolesperliter,multiplyby0.0259.
*Numbersvarybecauseofmissingdata.
for using a propensity score are described elsewhere.36-38 In populationcomparingsurvivorswiththosewhohavedied
brief,logisticregressionwasusedtodeterminewhichchar- areshowninTable1.Thosewhodiedweremorelikely
acteristics were associated with ocular disease without tobeolder;havehighersystolicandlowerdiastolicblood
regardtomortality.Theconditionalprobabilityoftheocular
pressures,lowerhigh-densitylipoproteincholesterollev-
diseasegiventheobservedcovariateswasoutputandstrati-
els,higherglycosylatedhemoglobinlevels,andahigher
fiedintoquintiles.Coxproportionalhazardmodelsinvesti-
gating ocular disease and mortality were then fit adjusting pulserate;consumelessalcohol;andhavesmokedmore
for the propensity score. Second, a stepwise procedure was pack-years.Inaddition,thosewhodiedweremorelikely
usedtodeterminenonocularriskfactorsformortality.These tobemale;tohavediabetes,hypertension,ahistoryofcar-
modelswerefurtherreducedtopreventoveradjustment.For diovasculardisease,cancer,emphysema,gout,arthritis,
example, glycosylated hemoglobin level and diabetes status
gross proteinuria, a sedentary lifestyle, and less educa-
werebothsignificantlyassociatedwithmortality.Wechose
tion;andtobecurrentlyusingdiureticsandaspirin.
toadjustfordiabetesstatusonly.However,reducedmodels
Univariateanalysesforeyediseaseandmortalityshowed
were very similar to the models adjusting for all variables
significantly associated with mortality. Some relationships thatpersonswithcorticalcataract,posteriorsubcapsular
were stronger in men than women, so analyses were run cataract,cataractsurgery,glaucoma,visualimpairment,and
separatelybysex.Additionalstratifiedanalyseswererunfor moreseverelevelsofnuclearsclerosis,ARM,anddiabetic
diabetesstatusandage(using65yearsofageasacutoff). retinopathy had greater mortality than persons without
(Table2).Aftercontrollingforageandsex,onlyincreas-
RESULTS ingseverityofnuclearsclerosis,corticalcataract,anycata-
ract,diabeticretinopathy,andvisualimpairmentwerestill
ByDecember31,2002(medianfollow-up,13.2years),we significant(Table3andFigure1).
confirmedbydeathcertificatethat32%(n=1576)ofthe Tofurtherevaluatetherelationshipsofoculardisease
baselinecohorthaddied.Baselinecharacteristicsofthe withmortality,wedevelopedmultivariatemodelsusing
(REPRINTED)ARCHOPHTHALMOL/VOL124, FEB2006 WWW.ARCHOPHTHALMOL.COM
245
©2006AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archopht.jamanetwork.com/ by a UNIVERSITAETSBIBLIOTHEK GIESSEN User on 05/29/2015
CI,0.93-1.46)wereattenuatedandnolongerstatistically
Table2.OcularConditionsbySurvivalStatus significant.Restrictingthecohorttopersonsyoungerthan
65yearsshowedasignificantrelationshipbetweenvisual
No.(%)ofSubjects impairmentanddecreasedsurvival(multivariateHR,2.18;
P
95%CI,1.02-4.67)andasignificantrelationshipofpoorer
OcularCondition Survivors Died Value
survivalwithincreasingseverityofnuclearsclerosis(mul-
Nuclearsclerosisseverity (cid:3).001
tivariateHRper1-stepincreaseinseverity,1.22;95%CI,
Level1 280(8.6) 25(1.8)
Level2 1571(48.1) 295(21.2) 1.03-1.43).Corticalcataractwasnotassociatedwithmor-
Level3 1074(32.9) 617(44.3) talityinthisyoungersubgroup.Restrictingthecohortto
Level4 311(9.5) 408(29.3) persons65yearsorolder,thecorticalcataractrelation-
Level5 30(0.9) 48(3.5) shipremained;however,thevisualimpairmentrelation-
Corticalcataractpresent 3273(10.2) 1380(29.2) (cid:3).001
shipwasattenuatedaftermultivariateadjustment(HR,1.19;
PSCpresent 3287(3.7) 1393(8.3) (cid:3).001
95%CI,0.99-1.43).Whenpersonswithdiabeteswereex-
Cataractsurgerypresent 3350(3.0) 1573(11.1) (cid:3).001
Anycataractpresent 3315(21.0) 1497(55.9) (cid:3).001 cluded,allsignificantrelationshipsshowninTable3re-
Glaucomapresent 3243(3.0) 1370(7.4) (cid:3).001 mainedsignificant.Restrictingtheanalysistopersonswith
Age-relatedmaculopathy (cid:3).001 diabetes(n=446),theonlysignificantrelationshipwasfor
None 2733(83.2) 1026(70.2) increasingseverityofdiabeticretinopathy(Table3).
Early 527(16.0) 382(26.1) Ofthe1576deaths,56%hadamentionofheartdisease,
Late 25(0.8) 54(3.7)
28%hadamentionofcancer,and13%hadamentionof
Diabeticretinopathy .002
strokeontheirdeathcertificates.Cause-specificmortality
None 135(71.0) 141(57.3)
Mild 36(18.9) 66(26.8) wasinvestigatedinthese3groupsusingthesamemethods
Moderate 19(10.0) 31(12.6) describedforall-causemortality.Aseparateselectionpro-
Proliferative 0 8(3.3) cedurewasusedforeachcauseofdeathtodeterminemul-
Visualimpairment 3336(1.9) 1561(12.2) (cid:3).001 tivariateadjustment(resultsnotshown).Aftermultivar-
present
iateadjustment,personswithocularconditionsgenerally
hadanincreasedspecific-causemortalityrisk;however,only
Abbreviation:PSC,posteriorsubcapsularcataract.
*Numbersvarybecauseofmissingdata. afewrelationshipswerestatisticallysignificant(Figure2).
Increasingdiabeticretinopathyseveritywasassociatedwith
anymentionofheartdiseasemortality(multivariate-adjusted
2differentmethods.First,apropensityscorewascalcu- HR,1.53;95%CI,1.25-1.88),andincreasingnuclearscle-
latedforeachriskfactorandthencontrolledforinCox rosisseveritywasassociatedwithanymentionofstrokemor-
proportionalhazardsmodels.Second,afullyadjustedmul- tality(multivariate-adjustedHR,1.29;95%CI,1.03-1.61).
tivariatemodelwasdeveloped.Atotalof27characteris- Therewerenosignificantassociationsbetweenocularcon-
ticsofvariousmedicalandlifestylecharacteristics(listed ditionsandcancermortality.
inTable1)wereconsidered,andafteranextensiveinves-
tigationitwasdeterminedthatthenonocularcorrelatesof
COMMENT
deathinthepopulationincludedage,sex,grossprotein-
uria,historyofcancer,bodymassindex(BMI),BMI2,ra- Byusingstandardizedprotocolsfortheexamination,pho-
tioofserumlevelsoftotaltohigh-densitylipoproteincho- tography,andgradingofoculardisease,theBeaverDam
lesterol, smoking, pulse rate, diabetes status, history of EyeStudyoffersauniqueopportunitytoinvestigateocu-
cardiovasculardisease,sedentarylifestyle,education,and lardiseaseasamarkerformortality.Althoughaprevious
systolicbloodpressure(datanotshown).Withtheexcep- report of mortality in this population9 included deaths
tionofnuclearsclerosisseverityanddiabeticretinopathy, throughNovember1993(medianfollow-up,4years),the
theresultsweresimilarbetweenthepropensityandthemul- presentanalysisincludedanadditional9to10yearsoffollow-
tivariatemodels(Table3).Corticalcataract,anycataract, upand1109additionaldeaths.Wehadfoundthatsever-
andvisualimpairmentwereallsignificantlyassociatedwith ityofnuclearsclerosisandvisualimpairmentwereasso-
increasedmortalityafterbothtypesofadjustment.Nuclear ciatedwithpoorersurvival,butthataftercontrollingformul-
sclerosisseverityremainedsignificantlyassociatedwithin- tiplesystemicandlifestylefactors,noneoftheassociations
creasedmortalityafteradjustingforthepropensityscore werestatisticallysignificant.Whenweusedtheadditional
butwasmarginallysignificantinthefullyadjustedmodel. deathsandfollow-upandinvestigatedmoredetailedmul-
Diabeticretinopathyseveritywasmarginallysignificantin tivariateadjustments,wefoundsimilarassociations.These
associationwithmortalityafteradjustingforthepropen- relationshipsremainedsignificantafteradjustingforpo-
sityscoreandwassignificantinthefullyadjustedmodel. tentialconfoundersandotherriskfactorsformortality,al-
Toevaluatetheserelationshipsfurther,westratified thoughforsomeanalysestheassociationfornuclearscle-
analyses by sex, age ((cid:3)65 vs (cid:1)65 years), and diabetes rosiswasmarginallysignificant.Inaddition,thepresence
status.Whenrestrictedtomenonly,thesignificantrela- ofcorticalcataractandseverityofdiabeticretinopathywere
tionshipsshowninTable2remainedsignificant.When associatedwithpoorersurvivalinthecurrentanalysis.
restrictedtowomenonly,therelationshipsbetweencor- Relationshipsbetweeneyediseaseandmortalitywere
ticalcataract(multivariate-adjustedhazardratio[HR],1.09; strongerinmeninourstudy.Womenlivelongerandhave
95% confidence interval [CI], 0.92-1.30), any cataract a better chance of development of eye and other age-
(multivariate-adjustedHR,1.12;95%CI,0.93-1.34),and relatedcomorbidconditions,whereasmendieearlierin
visualimpairment(multivariate-adjustedHR,1.17;95% lifeandaremorelikelytohavefewercomorbidcondi-
(REPRINTED)ARCHOPHTHALMOL/VOL124, FEB2006 WWW.ARCHOPHTHALMOL.COM
246
©2006AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archopht.jamanetwork.com/ by a UNIVERSITAETSBIBLIOTHEK GIESSEN User on 05/29/2015
1.0
0.9
0.8
1
2
3
0.7 4
5
0.6
0 2 4 6 8 10 12 14 16
Years of Survival
Table3.AssociationofOcularVariablesWithDecreasedSurvival
AgeandSexAdjusted PropensityScoreAdjusted* FullMultivariateAdjusted†
RiskFactor HR(95%CI) PValue HR(95%CI) PValue HR(95%CI) PValue
Nuclearcataractpresent 1.11(0.97-1.26) .12 1.13(0.99-1.28) .07 1.09(0.96-1.24) .20
Nuclearsclerosisper1-stepincreaseinseverity‡ 1.11(1.02-1.20) .01 1.13(1.05-1.22) .002 1.07(0.99-1.16) .08
Corticalcataractpresent 1.22(1.07-1.39) .002 1.19(1.05-1.34) .007 1.21(1.06-1.37) .004
PSCpresent 1.12(0.92-1.37) .25 1.03(0.85-1.25) .74 1.07(0.88-1.31) .48
Cataractsurgerypresent 1.12(0.95-1.33) .18 1.16(0.98-1.36) .09 0.92(0.77-1.09) .34
Anycataractpresent 1.28(1.13-1.45) (cid:3).001 1.24(1.09-1.40) (cid:3).001 1.16(1.03-1.32) .02
Glaucomapresent 1.09(0.88-1.34) .44 1.12(0.91-1.38) .27 1.04(0.84-1.28) .74
ARMper1-stepincreaseinseverity‡ 0.97(0.88-1.08) .63 1.03(0.94-1.14) .51 0.97(0.87-1.07) .54
Diabeticretinopathyper1-stepincreaseinseverity‡§ 1.41(1.18-1.67) (cid:3).001 1.17(0.99-1.39) .07 1.36(1.14-1.63) (cid:3).001
Visualimpairmentpresent 1.42(1.19-1.69) (cid:3).001 1.51(1.28-1.77) (cid:3).001 1.24(1.04-1.48) .02
Abbreviations:ARM,age-relatedmaculopathy;CI,confidenceinterval;HR,hazardratio;PSC,posteriorsubcapsularcataract.
*Indicatesadifferentsetofcovariatesusedforeachriskfactor,includingage,sex,education,aspirinuse,andsmokingfornuclearcataract;age,sex,diabetes
status,systolicbloodpressure,andeducationforcorticalcataract;age,smoking,diabetesstatus,andcurrentuseofmedicationforhighbloodpressureforPSC;
age,smoking,diabetesstatus,diastolicbloodpressure,proteinuria,arthritis,andaspirinuseforcataractsurgery;age,sex,smoking,emphysema,diabetesstatus,
andhistoryofheavydrinkingforanycataract;age,sex,systolicbloodpressure,andhistoryofgoutforglaucoma;age,cholesterollevel,andhistoryofheavy
drinkingforARM;age,sex,diabetesstatus,smoking,education,andemphysemaforvisualimpairment;andage,glycosylatedhemoglobinlevel,proteinuria,total
cholesterollevel,systolicbloodpressure,currentaspirinuse,andbodymassindex(BMI)fordiabeticretinopathy.
†Indicatesadjustedforage,sex,proteinuria,historyofcancer,BMI,BMI2,ratiooftotaltohigh-densitylipoproteincholesterollevel,smoking,pulserate,
diabetesstatus,cardiovasculardiseasehistory,sedentarylifestyle,education,andsystolicbloodpressure.
‡Describedinthe“ProceduresandDefinitions”subsectionofthe“Methods”sectionandTable2.
§Assessedin446personswithdiabetes.
tions.Therefore,itispossiblethatothervariablesaremore increasedmortalityrisksthanothertypesofcataract.6,14,15,18,20,21
likely to confound a relationship between ocular dis- Therewasincreasedriskofoverallmortalityandstroke-related
easeandmortalityinwomenthaninmen. mortalitywithincreasingseverityofnuclearsclerosisinour
Associationsbetweencataractandmortalityhavebeen study,althoughtherelationshiptonuclearcataract,themost
investigatedinmanystudies.1,2,4,6,9,13-16,18-21Nuclearsclero- severecategorizationofsclerosis,wasofborderlinesignifi-
sisormixedcataracttypesaremoreoftenassociatedwith cance.Theassociationbetweennuclearcataractanddecreased
noitroporP
lavivruS
A
1.0
0.9
0.8
Absent
0.7
Present
0.6
0 2 4 6 8 10 12 14 16
Years of Survival
noitroporP
lavivruS
B
1.0
0.9
0.8
Absent
0.7
Present
0.6
0 2 4 6 8 10 12 14 16
Years of Survival
noitroporP
lavivruS
C
1.0
0.8 None
0.6 Mild
0.4 Moderate
0.2
Proliferative
0.0
0 2 4 6 8 10 12 14 16
Years of Survival
noitroporP
lavivruS
D
Figure1.Age-andsex-adjustedsurvivalcurvesareshownfornuclearsclerosisseverity(A),corticalcataract(B),visualimpairment(C),anddiabeticretinopathy
severity(D).Fordiabeticretinopathy,thepopulationisrestrictedto446personswithdiabetesatbaseline,andtheverticalaxisisonadifferentscalecompared
withtheotherocularconditions.
(REPRINTED)ARCHOPHTHALMOL/VOL124, FEB2006 WWW.ARCHOPHTHALMOL.COM
247
©2006AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archopht.jamanetwork.com/ by a UNIVERSITAETSBIBLIOTHEK GIESSEN User on 05/29/2015
A B C
Nuclear Sclerosis per
1-Step Increase in Severity
Cortical Cataract Present
Posterior Subcapsular
Cataract Present
Glaucoma Present
ARM per 1-Step Increase
in Severity
Diabetic Retinopathy per
1-Step Increase in Severity
Visual Impairment Present
0.0 0.5 1.0 1.5 2.0 2.5 0.0 0.5 1.0 1.5 2.0 2.5 0.0 0.5 1.0 1.5 2.0 2.5
Adjusted Hazard Ratio Adjusted Hazard Ratio Adjusted Hazard Ratio
Figure2.Multivariate-adjustedhazardratios(and95%confidenceintervals)ofoculardiseaseforspecific-causemortalityareplottedforanymentionofheart
disease(A),anymentionofcancer(B),andanymentionofstroke(C).Hazardratiosforheartdiseasemortalitywereadjustedbyage,sex,bodymassindex(BMI),
BMI2,ratiooftotaltohigh-densitylipoproteincholesterollevel,smokinghistory,pulse,diabetesstatus,sedentarylifestyle,education,andsystolicbloodpressure.
Hazardratiosforcancermortalitywereadjustedbyage,sex,BMI,BMI2,cholesterollevel,smokinghistory,pulse,andeducation.Hazardratioswereadjustedfor
strokemortalitybyage,sex,BMI,BMI2,proteinuria,systolicbloodpressure,anddiabetesstatus.ARMindicatesage-relatedmaculopathy.Increasinglevelsof
severityofnuclearsclerosis,ARM,anddiabeticretinopathyaredescribedinthe“ProceduresandDefinitions”subsectionofthe“Methods”sectionandinTable2.
survivalcouldbearesultofchangesinstructuralproteins Age-relatedmaculopathywasnotassociatedwithmor-
thatareubiquitousthroughoutthebody.Suchchangeshave tality in the Rotterdam Eye Study2 or the Blue Moun-
beenhypothesizedtoresultfromoxidation,13theformation tains Eye Study.19 However, the Age-Related Eye Dis-
ofdisulfidebinding,18orotherage-relatedproteinchanges39 easeStudyshowedanincreasedmortalityriskinpersons
thatcausediminishedfunction.Reasonsforanassociation with advanced-stage macular degeneration.4 In addi-
specificallywithstrokedeathareunclearandmaybeare- tion, a recent study from the Copenhagen Eye Study
sultofchancebecausespecific-causemortalitymayinclude showedanincreasedmortalityriskinwomenbutnotmen
somemisclassification. withARM.3Datafromourstudysuggestthatthereisno
Wefoundasignificantassociationbetweencorticalcata- relationshipbetweenARMandmortality.Thelowpreva-
ractandincreasedmortality,independentofothersystemic lenceoflateARMordifferencesincumulatedmortality
riskfactors.OnlytheBlueMountainsEyeStudy19haspre- ratesmayexplainsomedifferences.Wedidnotexpect
viouslyreportedthisfinding,butunlikeourstudy,theas- tofindanassociationbecausedatafromtheBeaverDam
sociationwasnolongersignificantafterexcludingpersons Eye Study have shown that ARM is weakly and incon-
withdiabetes.Amongthepersonalandenvironmentalrisk sistentlyassociatedwithmeasuresoffrailtyandnotas-
factorsassociatedwithcorticalcataractasidefromage,dia- sociated with cardiovascular disease, stroke, and can-
beteshasbeenthemostconsistentfactor.Glycosylationof cer,themaincausesofdeath.48,49
lensproteinsmayinpartberesponsible.40Alevelofgly- Diabeticretinopathywassignificantlyassociatedwith
cemiabelowthecutpointforovertdiabetesmaybesuffi- mortality.Althoughoursamplesizewassmaller,these
cienttocauseglycosylationoflensproteins.Thelevelof results are consistent with those found in the Wiscon-
glycemiainthosenotdiagnosedashavingdiabeteshasbeen sinEpidemiologicStudyofDiabeticRetinopathyandother
showntobeassociatedwithriskofdeath,usuallycaused studies.8,10,22,23Thesedataareconsistentwiththespecu-
bycardiovascularfactors.41,42Also,UVlightexposureap- lationthatretinopathyseveritymaybeamarkerofsimi-
pearstoincreaseriskofcorticalcataract.43,44Exposureto larmicrovasculardiseaseaffectingotherorgansystems
UVlightcanproduceoxidativestressintheeye,resulting inpersonswithdiabetes(eg,heartandkidney).
incorticalcataract;similarsensitivitytoothersystemiccauses Frailtyhasbeenshowntobeastrongpredictorofmor-
ofoxidativestressmaybeamechanismforincreasedsys- tality.50Recentresearchhassuggestedthatvisualacuityis
temicmorbidity.45,46Finally,ageneticcomponenttocor- associatedwithotherfrailtymarkers(eg,handgripstrength
ticalcataractexists.47Geneticfactorsrelatedtocorticalcata- andpeakexpiratoryflow)andinitselfmaybeconsidered
ractmayalsobelinkedtodecreasedlongevity. anothermeasureoffrailty.51Therefore,itwasnotsurpris-
Otherstudieshaveshownanincreasedriskamongper- ingthatvisualimpairmentwasassociatedwithpoorersur-
sonswhohaveundergonecataractsurgery.1,13,16Wedidnot vivalinourstudy.Decreasedvisualacuitywasassociated
findthisinourstudy.Itcouldbethatpersonswhohave withmortalityinotherpopulation-basedstudiessuchas
hadcataractsurgeryaremorehealthconsciousandhavea the Blue Mountains Eye Study19 and the Visual Impair-
healthierlifestylethanthosewhodidnot.Forexample,in ment Project12 and in the case-control arm of the Age-
ourstudypersonswhohadundergonecataractsurgerywere RelatedEyeDiseaseStudyClinicaltrial.4Thevisualsys-
morelikelytobetakingvitaminsupplements(M.D.K.,un- temispartofthecentralnervoussystem.Retinalganglion
publisheddata,May2005).Also,personswhohaveun- cellsdecreaseinnumberwithincreasingage.Therefore,
dergonecataractsurgerymayhavebetterhealthcareand itisnotsurprisingthatdecreasedvision,asareflectionof
mayundergocataractsurgerywithlessseverelenschanges biologicalagingindependentofthespecificage-relatedeye
thanpersonswithpooreraccesstohealthcareservices. diseases,isindependentlyassociatedwithmortality.
(REPRINTED)ARCHOPHTHALMOL/VOL124, FEB2006 WWW.ARCHOPHTHALMOL.COM
248
©2006AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archopht.jamanetwork.com/ by a UNIVERSITAETSBIBLIOTHEK GIESSEN User on 05/29/2015
TheBeaverDamEyeStudyhasmanystrengthsforin- lation-basedlongitudinalstudy.BullWorldHealthOrgan.1992;70:219-223.
15. NucciC,CedroneC,CulassoF,etal.Associationbetweenlensopacitiesandmor-
vestigatingrelationshipsbetweenocularconditionsandmor-
talityinthePrivernoEyeStudy.GraefesArchClinExpOphthalmol.2004;242:
tality,includingthepopulation-baseddesign,largesample 289-294.
size,long-termfollow-up,useofstandardizedprocedures, 16. StreetDA,JavittJC.Nationalfive-yearmortalityafterinpatientcataractextraction.
AmJOphthalmol.1992;113:263-268.
andamoderatelyhighmortalityrateof32%.However,we
17. TaylorHR,McCartyCA,NanjanMB.Visionimpairmentpredictsfive-yearmortality.
cannotexcludethepossibilitythatsomeoftheassociations TransAmOphthalmolSoc.2000;98:91-96.
maybefalse.Theconclusionsregardingassociationsorlack 18. ThompsonJR,SparrowJM,GibsonJM,RosenthalAR.Cataractandsurvivalin
anelderlynondiabeticpopulation.ArchOphthalmol.1993;111:675-679.
ofthemmustbedrawnwithcautionforseveralreasons.First,
19. WangJJ,MitchellP,SimpsonJM,CummingRG,SmithW.Visualimpairment,
uncontrolledconfoundingislikelytobeatleastpartlythe age-relatedcataract,andmortality.ArchOphthalmol.2001;119:1186-1190.
explanationforsomeoftheassociations.Eyeconditionsmay 20. WestSK,MunozB,IstreJ,etal.Mixedlensopacitiesandsubsequentmortality.
ArchOphthalmol.2000;118:393-397.
onlybemarkersforunderlyingetiologicfactorscausingdeath.
21. WilliamsSL,FerrignoL,MoraP,RosminiF,MarainiG.Baselinecataracttype
Second,someassociationsmaybeduetoachancefinding, and10-yearmortalityintheItalian-Americancase-controlstudyofage-related
giventherelativelylargenumbersofassociationsexamined. cataract.AmJEpidemiol.2002;156:127-131.
22. DavisMD,HillerR,MagliYL,etal.Prognosisforlifeinpatientswithdiabetes:re-
Third,therelativelylowfrequencyofcertainvariablessuch
lationtoseverityofretinopathy.TransAmOphthalmolSoc.1979;77:144-170.
aslateARMandoutcomessuchasstrokemortalitylimits 23. SharmaNK,ArcherDB,HaddenDR,MerrettJD,MaguireCJ.Morbidityandmor-
theabilitytodetectorrejectmeaningfulrelationshipsbe- talityinpatientswithdiabeticretinopathy.TransOphthalmolSocUK.1980;
100:83-89.
causeoflowpower.Fourth,itispossiblethatnorelation-
24. KleinR,KleinBE,LintonKL,DeMetsDL.TheBeaverDamEyeStudy:visualacuity.
shipswerefoundbetweensomeocularfactorsandmortal- Ophthalmology.1991;98:1310-1315.
itybecauseofsurvivalbiasbecausesubjectswhodeveloped 25. HypertensionDetectionandFollow-upProgramCooperativeGroup.Thehyper-
tensiondetectionandfollow-upprogram.PrevMed.1976;5:207-215.
ocularfactorsthatalsopredisposedthemtodeathafterthe
26. KleinR,KleinBE.TheBeaverDamEyeStudyManualofOperations.Springfield,
baselineexaminationwerenotincluded.Nevertheless,our Va:USDeptofCommerce;1991.NTISaccessionNo.PB91-149823.
datasuggestthatage-relatedcorticalcataract,nuclearscle- 27. KleinR,KleinBE,MossSE.Diabetes,hyperglycemia,andage-relatedmaculopa-
thy:theBeaverDamEyeStudy.Ophthalmology.1992;99:1527-1534.
rosisseverity,diabeticretinopathy,andvisualimpairment
28. DiabeticRetinopathyStudyResearchGroup.ReportNo.7:amodificationofthe
mayserveasimportantmarkersformortalityinthegeneral AirlieHouseclassificationofdiabeticretinopathy.InvestOphthalmolVisSci.1981;
population. 21(1,pt2):1-226.
29. KleinBE,KleinR,LintonKL,MagliYL,NeiderMW.Assessmentofcataractsfrom
Submitted for Publication: June 21, 2005; final revi- photographsintheBeaverDamEyeStudy.Ophthalmology.1990;97:1428-1433.
30. KleinR,DavisMD,MagliYL,SegalP,KleinBE,HubbardL.TheWisconsinage-
sionreceivedJuly27,2005;acceptedJuly29,2005.
relatedmaculopathygradingsystem.Ophthalmology.1991;98:1128-1134.
Correspondence: Michael D. Knudtson, MS, Depart- 31. KleinR,KleinBE,LintonKL.Prevalenceofage-relatedmaculopathy:theBeaver
mentofOphthalmologyandVisualSciences,University DamEyeStudy.Ophthalmology.1992;99:933-943.
32. KleinBE,KleinR,SponselWE,etal.Prevalenceofglaucoma:theBeaverDam
ofWisconsinMedicalSchool,Madison,610NWalnut
EyeStudy.Ophthalmology.1992;99:1499-1504.
St, Fourth Floor WARF, Madison, WI 53726-2336 33. EarlyTreatmentDiabeticRetinopathyStudyResearchGroup. Fundusphoto-
(knudtson@epi.ophth.wisc.edu). graphicriskfactorsforprogressionofdiabeticretinopathy:ETDRSreportnum-
ber12.Ophthalmology.1991;98:823-833.
FinancialDisclosure:None.
34. SASInstituteInc.SAT/STATUser’sGuide,Version8.Cary,NC:SASInstituteInc;1999.
Funding/Support: This study was supported by grant 35. AllisonPD.SurvivalAnalysisUsingtheSASSystem:APracticalGuide.Cary,NC:
EY06594fromtheNationalInstitutesofHealth,Bethesda, SASInstituteInc;1995.
36. CookEF,GoldmanL.Performanceoftestsofsignificancebasedonstratifica-
Md(DrsR.KleinandB.E.K.Klein).
tionbyamultivariateconfounderscoreorbyapropensityscore.JClinEpidemiol.
1989;42:317-324.
37. DrakeC,FisherL.Prognosticmodelsandthepropensityscore.IntJEpidemiol.
REFERENCES 1995;24:183-187.
38. JoffeMM,RosenbaumPR.Invitedcommentary:propensityscores.AmJEpidemiol.
1999;150:327-333.
1. BensonWH,FarberME,CaplanRJ.Increasedmortalityratesaftercataractsur-
39. BosciaF,GrattaglianoI,VendemialeG,Micelli-FerrariT,AltomareE.Proteinoxida-
gery:astatisticalanalysis.Ophthalmology.1988;95:1288-1292.
tionandlensopacityinhumans.InvestOphthalmolVisSci.2000;41:2461-2465.
2. BorgerPH,vanLeeuwenR,HulsmanCA,etal.Isthereadirectassociationbe-
tweenage-relatedeyediseasesandmortality?theRotterdamStudy. 40. GarlickRL,MazerJS,ChylackLTJr,TungWH,BunnHF.Nonenzymaticglyca-
Ophthalmology.2003;110:1292-1296. tionofhumanlenscrystalline.JClinInvest.1984;74:1742-1749.
3. BuchH,VindingT,laCourM,JensenGB,PrauseJU,NielsenNV.Age-related 41. BalkauB,BertraisS,DucimetiereP,EschwegeE.Isthereaglycemicthreshold
maculopathy:ariskindicatorforpoorersurvivalinwomen:theCopenhagenCity formortalityrisk?DiabetesCare.1999;22:696-699.
EyeStudy.Ophthalmology.2005;112:305-312. 42. GersteinHC.Isglucoseacontinuousriskfactorforcardiovascularmortality?
4. ClemonsTE,KurinijN,SperdutoRD.Associationsofmortalitywithoculardisor- DiabetesCare.1999;22:659-660.
dersandaninterventionofhigh-doseantioxidantsandzincintheAge-RelatedEye 43. CruickshanksKJ,KleinBE,KleinR.Ultravioletlightexposureandlensopacities:
DiseaseStudy:AREDSreportNo.13.ArchOphthalmol.2004;122:716-726. theBeaverDamEyeStudy.AmJPublicHealth.1992;82:1658-1662.
5. GrodumK,HeijlA,BengtssonB.Glaucomaandmortality.GraefesArchClinExp 44. TaylorHR,WestSK,RosenthalFS,etal.Effectofultravioletradiationoncata-
Ophthalmol.2004;242:397-401. ractformation.NEnglJMed.1988;319:1429-1433.
6. HennisA,WuSY,LiX,NemesureB,LeskeMC;BarbadosEyeStudyGroup.Lensopaci- 45. SteinbergD,ParthasarathyS,CarewTE,KhooJC,WitztumJL.Beyondcholes-
tiesandmortality:theBarbadosEyeStudies.Ophthalmology.2001;108:498-504. terol:modificationsoflow-densitylipoproteinthatincreaseitsatherogenicity.
7. HillerR,PodgorMJ,SperdutoRD,WilsonPW,ChewEY,D’AgostinoRB.High NEnglJMed.1989;320:915-924.
intraocularpressureandsurvival.AmJOphthalmol.1999;128:440-445. 46. WitztumJL.Theoxidationhypothesisofatherosclerosis.Lancet.1994;344:793-795.
8. KleinR,MossSE,KleinBE,DeMetsDL.Relationofocularandsystemicfactors 47. IyengarSK,KleinBE,KleinR,etal.Identificationofamajorlocusforage-
tosurvivalindiabetes.ArchInternMed.1989;149:266-272. relatedcorticalcataractonchromosome6p12-q12intheBeaverDamEyeStudy.
9. KleinR,KleinBE,MossSE.Age-relatedeyediseaseandsurvival:theBeaverDam ProcNatlAcadSciUSA.2004;101:14485-14490.
EyeStudy.ArchOphthalmol.1995;113:333-339. 48. KleinR,KleinBE,KnudtsonMD.Frailtyandage-relatedmaculardegeneration:
10. KleinR,KleinBE,MossSE,CruickshanksKJ.Associationofoculardiseaseand theBeaverDamEyeStudy.AmJOphthalmol.2005;140:129-131.
mortalityinadiabeticpopulation.ArchOphthalmol.1999;117:1487-1495. 49. KleinR,KleinBE,TomanySC,CruickshanksKJ.Theassociationofcardiovas-
11. LeeDJ,Gomez-MarinO,LamBL,ZhengDD.Visualacuityimpairmentandmor- culardiseasewiththelong-termincidenceofage-relatedmaculopathy:theBea-
talityinUSadults.ArchOphthalmol.2002;120:1544-1550. verDamEyeStudy.Ophthalmology.2003;110:1273-1280.
12. McCartyCA,NanjanMB,TaylorHR.Visionimpairmentpredicts5yearmortality. 50. KleinBE,KleinR,KnudtsonMD,LeeKE.Frailty,morbidity,andsurvival.Arch
BrJOphthalmol.2001;85:322-326. GerontolGeriatr.2005;41:141-149.
13. MeddingsDR,HertzmanC,BarerML,etal.Socioeconomicstatus,mortality,and 51. KleinBE,KleinR,KnudtsonMD,LeeKE.Relationshipofmeasuresoffrailtyto
thedevelopmentofcataractatayoungage.SocSciMed.1998;46:1451-1457. visualfunction:theBeaverDamEyeStudy.TransAmOphthalmolSoc.2003;
14. MinassianDC,MehraV,JohnsonGJ.Mortalityandcataract:findingsfromapopu- 101:191-196.
(REPRINTED)ARCHOPHTHALMOL/VOL124, FEB2006 WWW.ARCHOPHTHALMOL.COM
249
©2006AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archopht.jamanetwork.com/ by a UNIVERSITAETSBIBLIOTHEK GIESSEN User on 05/29/2015
